BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Weiler N, Zeuzem S, Welker MW. Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection. World J Gastroenterol 2016; 22(41): 9044-9056 [PMID: 27895394 DOI: 10.3748/wjg.v22.i41.9044]
URL: https://www.wjgnet.com/1007-9327/full/v22/i41/9044.htm
Number Citing Articles
1
Anil C. Anand. Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?Journal of Clinical and Experimental Hepatology 2017; 7(1): 42 doi: 10.1016/j.jceh.2017.01.116
2
Xiaobo Zhu, Mingqi Wang, Mei Liu, Xinghao Yu, Peng Huang. Efficacy and safety of direct-acting antivirals for treatment-naive patients with genotype 1 hepatitis C virus infectionPersonalized Medicine 2019; 16(5): 421 doi: 10.2217/pme-2018-0121
3
Phillip P. Santoiemma, Stephen H. Dinwiddie, Michael P. Angarone. Infectious Disease Complications in People Who Inject DrugsPsychiatric Annals 2017; 47(1): 33 doi: 10.3928/00485713-20161206-03
4
Christian Rupp, Theresa Hippchen, Manuel Neuberger, Peter Sauer, Jan Pfeiffenberger, Wolfgang Stremmel, Daniel Nils Gotthardt, Arianeb Mehrabi, Karl-Heinz Weiss. Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virusWorld Journal of Gastroenterology 2018; 24(12): 1353-1360 doi: 10.3748/wjg.v24.i12.1353
5
Bing Xu, Yang Deng, Xin Li, Siwei Guo, Zhenyue Gao, Wenyuan Xu, Yuan Li, Ping Zhang, Lingling Zhang, Junchen Huang. Development and validation of a LC-MS/MS method for simultaneous determination of TQ-A3326 and its major metabolites in human plasma, urine and feces: application to pharmacokinetic assayXenobiotica 2020; 50(12): 1451 doi: 10.1080/00498254.2020.1781292